Caremax Stock EBITDA

CMAX Stock

USD 0.42 0.15 26.32%

CareMax fundamentals help investors to digest information that contributes to CareMax's financial success or failures. It also enables traders to predict the movement of CareMax Stock. The fundamental analysis module provides a way to measure CareMax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CareMax stock.

		Last Reported	Projected for Next Year
	EBITDA	-590.5 M	-560.9 M

EBITDA is likely to rise to about (560.9 M) in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CareMax Company EBITDA Analysis

CareMax's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current CareMax EBITDA

(590.46 M)

Most of CareMax's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CareMax is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

CareMax EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for CareMax is extremely important. It helps to project a fair market value of CareMax Stock properly, considering its historical fundamentals such as EBITDA. Since CareMax's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CareMax's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CareMax's interrelated accounts and indicators.

	Net Tangible Assets	Accounts Payable	Net Receivables	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Total Stockholder Equity	Net Debt	Good Will	Total Liab	Short Term Debt	Intangible Assets	Current Deferred Revenue	Retained Earnings	Long Term Debt	Short Term Investments	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Long Term Debt Total	Deferred Long Term Liab
Net Tangible Assets		-0.94	-0.94	-0.91	0.86	-0.99	-0.87	-0.51	-0.97	-0.73	-0.96	-0.78	-0.93	-0.85	0.76	-0.51	0.69	-0.81	-0.84	-0.77	0.86	0.51	0.69	0.95
Accounts Payable	-0.94		1.0	0.98	-0.87	0.88	0.95	0.71	0.86	0.83	0.99	0.58	0.99	0.9	-0.57	0.7	-0.43	0.9	0.9	0.58	-0.87	-0.26	-0.43	-0.8
Net Receivables	-0.94	1.0		0.98	-0.86	0.88	0.95	0.71	0.85	0.83	0.99	0.57	0.99	0.89	-0.55	0.71	-0.42	0.89	0.9	0.56	-0.86	-0.25	-0.42	-0.79
Total Current Assets	-0.91	0.98	0.98		-0.93	0.87	0.96	0.74	0.86	0.85	0.97	0.61	1.0	0.96	-0.6	0.67	-0.45	0.97	0.93	0.6	-0.93	-0.29	-0.45	-0.79
Common Stock	0.86	-0.87	-0.86	-0.93		-0.86	-0.93	-0.72	-0.86	-0.86	-0.87	-0.69	-0.94	-0.98	0.67	-0.57	0.61	-0.96	-0.95	-0.68	1.0	0.37	0.61	0.8
Property Plant Equipment	-0.99	0.88	0.88	0.87	-0.86		0.81	0.4	1.0	0.65	0.92	0.87	0.89	0.84	-0.85	0.37	-0.79	0.79	0.79	0.86	-0.86	-0.63	-0.79	-0.99
Total Assets	-0.87	0.95	0.95	0.96	-0.93	0.81		0.86	0.79	0.96	0.9	0.47	0.97	0.92	-0.45	0.81	-0.38	0.93	0.99	0.47	-0.93	-0.1	-0.38	-0.71
Total Stockholder Equity	-0.51	0.71	0.71	0.74	-0.72	0.4	0.86		0.38	0.95	0.6	0.0	0.74	0.71	0.03	0.95	0.05	0.75	0.87	-0.01	-0.72	0.38	0.05	-0.26
Net Debt	-0.97	0.86	0.85	0.86	-0.86	1.0	0.79	0.38		0.63	0.91	0.9	0.87	0.85	-0.88	0.32	-0.83	0.79	0.78	0.9	-0.86	-0.67	-0.83	-0.99
Good Will	-0.73	0.83	0.83	0.85	-0.86	0.65	0.96	0.95	0.63		0.75	0.28	0.87	0.82	-0.24	0.9	-0.25	0.83	0.97	0.27	-0.86	0.11	-0.25	-0.53
Total Liab	-0.96	0.99	0.99	0.97	-0.87	0.92	0.9	0.6	0.91	0.75		0.69	0.98	0.91	-0.68	0.58	-0.52	0.9	0.86	0.68	-0.87	-0.4	-0.52	-0.86
Short Term Debt	-0.78	0.58	0.57	0.61	-0.69	0.87	0.47	0.0	0.9	0.28	0.69		0.61	0.67	-1.0	-0.11	-0.95	0.59	0.49	1.0	-0.69	-0.92	-0.95	-0.93
Intangible Assets	-0.93	0.99	0.99	1.0	-0.94	0.89	0.97	0.74	0.87	0.87	0.98	0.61		0.95	-0.6	0.69	-0.48	0.95	0.95	0.61	-0.94	-0.28	-0.48	-0.81
Current Deferred Revenue	-0.85	0.9	0.89	0.96	-0.98	0.84	0.92	0.71	0.85	0.82	0.91	0.67	0.95		-0.66	0.56	-0.54	0.99	0.93	0.67	-0.98	-0.37	-0.54	-0.78
Retained Earnings	0.76	-0.57	-0.55	-0.6	0.67	-0.85	-0.45	0.03	-0.88	-0.24	-0.68	-1.0	-0.6	-0.66		0.14	0.93	-0.58	-0.46	-1.0	0.67	0.94	0.93	0.92
Long Term Debt	-0.51	0.7	0.71	0.67	-0.57	0.37	0.81	0.95	0.32	0.9	0.58	-0.11	0.69	0.56	0.14		0.16	0.61	0.78	-0.12	-0.57	0.48	0.16	-0.22
Short Term Investments	0.69	-0.43	-0.42	-0.45	0.61	-0.79	-0.38	0.05	-0.83	-0.25	-0.52	-0.95	-0.48	-0.54	0.93	0.16		-0.44	-0.43	-0.95	0.61	0.88	1.0	0.87
Capital Surpluse	-0.81	0.9	0.89	0.97	-0.96	0.79	0.93	0.75	0.79	0.83	0.9	0.59	0.95	0.99	-0.58	0.61	-0.44		0.92	0.59	-0.96	-0.28	-0.44	-0.71
Net Invested Capital	-0.84	0.9	0.9	0.93	-0.95	0.79	0.99	0.87	0.78	0.97	0.86	0.49	0.95	0.93	-0.46	0.78	-0.43	0.92		0.48	-0.95	-0.12	-0.43	-0.7
Short Long Term Debt	-0.77	0.58	0.56	0.6	-0.68	0.86	0.47	-0.01	0.9	0.27	0.68	1.0	0.61	0.67	-1.0	-0.12	-0.95	0.59	0.48		-0.68	-0.93	-0.95	-0.93
Capital Stock	0.86	-0.87	-0.86	-0.93	1.0	-0.86	-0.93	-0.72	-0.86	-0.86	-0.87	-0.69	-0.94	-0.98	0.67	-0.57	0.61	-0.96	-0.95	-0.68		0.37	0.61	0.8
Net Working Capital	0.51	-0.26	-0.25	-0.29	0.37	-0.63	-0.1	0.38	-0.67	0.11	-0.4	-0.92	-0.28	-0.37	0.94	0.48	0.88	-0.28	-0.12	-0.93	0.37		0.88	0.75
Long Term Debt Total	0.69	-0.43	-0.42	-0.45	0.61	-0.79	-0.38	0.05	-0.83	-0.25	-0.52	-0.95	-0.48	-0.54	0.93	0.16	1.0	-0.44	-0.43	-0.95	0.61	0.88		0.87
Deferred Long Term Liab	0.95	-0.8	-0.79	-0.79	0.8	-0.99	-0.71	-0.26	-0.99	-0.53	-0.86	-0.93	-0.81	-0.78	0.92	-0.22	0.87	-0.71	-0.7	-0.93	0.8	0.75	0.87

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict CareMax

Ebitda Over Time

CareMax Ebitda

Ebitda

(560.94 Million)

CareMax reported EBITDA of (590.46 Million) in 2023

According to the company disclosure, CareMax reported earnings before interest,tax, depreciation and amortization of (590.46 Million). This is 167.29% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 115.15% higher than that of the company.

CareMax EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CareMax's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CareMax could also be used in its relative valuation, which is a method of valuing CareMax by comparing valuation metrics of similar companies.

CareMax is currently under evaluation in ebitda category among its peers.

CareMax Institutional Holders

Institutional Holdings refers to the ownership stake in CareMax that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of CareMax's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CareMax's value.

		Shares
Avidity Partners Management Lp	2024-09-30	21.2 K
Hongkou Capital Lp	2024-06-30	20.6 K
Hrt Financial Llc	2024-06-30	14.8 K
Qube Research & Technologies	2024-06-30	13.3 K
Ubs Group Ag	2024-06-30	12.4 K
Tower Research Capital Llc	2024-06-30	5.2 K
Acadian Asset Management Llc	2024-06-30	2.5 K
Rhumbline Advisers	2024-06-30	2.1 K
Royal Bank Of Canada	2024-06-30	1.9 K
Morgan Stanley - Brokerage Accounts	2024-06-30	708.5 K
Deerfield Management Co	2024-09-30	530.2 K

CareMax Fundamentals

	Return On Equity	-3.28
	Return On Asset	-0.11
	Profit Margin	(1.00) %
	Operating Margin	(0.1) %
	Current Valuation	498.39 M
	Shares Outstanding	3.81 M
	Shares Owned By Insiders	24.17 %
	Shares Owned By Institutions	51.59 %
	Number Of Shares Shorted	209.53 K
	Price To Book	0.40 X
	Price To Sales	0 X
	Revenue	751.1 M
	Gross Profit	80.3 M
	EBITDA	(590.46 M)
	Net Income	(683.35 M)
	Cash And Equivalents	68.13 M
	Cash Per Share	0.78 X
	Total Debt	491.93 M
	Debt To Equity	0.37 %
	Current Ratio	6.06 X
	Book Value Per Share	(38.73) X
	Cash Flow From Operations	(46.91 M)
	Short Ratio	0.94 X
	Earnings Per Share	(208.91) X
	Target Price	42.4
	Number Of Employees	1.45 K
	Beta	0.68
	Market Capitalization	6.91 M
	Total Asset	623.3 M
	Retained Earnings	(720.94 M)
	Working Capital	(255.46 M)
	Net Asset	623.3 M

About CareMax Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CareMax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareMax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareMax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for CareMax Stock Analysis

When running CareMax's price analysis, check to measure CareMax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareMax is operating at the current time. Most of CareMax's value examination focuses on studying past and present price action to predict the probability of CareMax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareMax's price. Additionally, you may evaluate how the addition of CareMax to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC